Evidence map›Paper›PMID 35188474›Full record

ArticleJMIR serious games2022

Experiences of Patients Undergoing Chemotherapy With Virtual Reality: Mixed Methods Feasibility Study.

Anna Janssen, Jennifer Fletcher, Melanie Keep, Naseem Ahmadpour, Anika Rouf, Michael Marthick, Rebecca Booth

Open access · goldAbstract read
In one paragraph

Article in JMIR serious games, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Application of virtual reality for supportive care in cancer patients: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  3. Effectiveness of smartphone-based virtual reality relaxation (SVR) for enhancing comfort in cancer patients undergoing chemotherapy: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  4. Article
  5. Review
  6. Experiences and perceptions of cancer patients receiving virtual reality therapy: a meta‑synthesis of qualitative research.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anna Janssen *Research in Implementation Science and eHealth Group, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0001-6611-9651
Jennifer FletcherEducation Enterprise and Engagement, The University of Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0002-9846-9354
Melanie KeepSydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0001-9516-0303
Naseem AhmadpourSchool of Architecture, Design and Planning, The University of Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0003-1818-1930
Anika RoufFaculty of Science, The University of Sydney, Sydney, Australia.ORCID https://orcid.org/0000-0002-8523-402X
Michael MarthickValion Health, Sydney, Australia.ORCID https://orcid.org/0000-0002-1524-7968
Rebecca BoothChris O'Brien Lifehouse, Sydney, Australia.ORCID https://orcid.org/0000-0002-8300-399X
The University of Sydney · AUChris O’Brien Lifehouse · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent research into virtual reality (VR) use during chemotherapy shows that it can be an effective distraction intervention. However, there is limited research in adult patients and to investigate how VR can be sustainably implemented in health care organizations.

objectiveThe aim of this study was to explore the feasibility and acceptability of using VR for adult patients undergoing chemotherapy, and to identify the factors that would enable the sustained use of VR during chemotherapy in health care organizations.

methodsPatients undergoing chemotherapy were recruited to participate in a VR intervention during chemotherapy infusion. Participants were observed during the session and completed a postintervention survey. Each participant was invited to participate in a semistructured interview about their experience.

resultsA total of 18 patients participated in the study, 5 of whom participated in semistructured interviews. Findings indicated that the use of VR was acceptable for patients undergoing chemotherapy and the intervention was also feasible. Some participants felt that the VR was an effective distraction during chemotherapy infusion, although most still seemed to be aware of how long their treatment was taking. Although VR was acceptable and feasible to patients, interviews identified several barriers to sustained implementation, including access to a reliable app library and impact on staff workloads.

conclusionsVR was acceptable to patients with a diagnosis of cancer undergoing chemotherapy treatment. Patients found VR beneficial for breaking up the monotony of treatment, to provide an additional choice of activity in addition to other recreation, and in some instances as a distraction from the treatment itself. However, there are challenges to address if VR is to be implemented in practice for this patient group.

Indexed as

cancerchemotherapydigital healtheHealthmixed methods researchserious gamestreatmentvirtual healthvirtual reality

Identifiers

PMID35188474
PMCPMC8902671
OpenAlexW3212931749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.